Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp167 | Cell biology: osteoblasts and bone formation | ECTS2013

Adipogenesis occurs at the expense of osteoblast differentiation in primary osteoblasts deficient in protease-activated receptor 2

Kularathna Pamuditha , Pagel Charles N , Hooper John D , Mackie Eleanor J

The G protein-coupled receptor, protease-activated receptor 2 (PAR2), is expressed by osteoblasts and required for normal skeletal growth and repair. Prostate cancer (PCa) cells commonly secrete proteolytic activators of PAR2 (including matriptase and kallikrein-related peptidase 4) and frequently form osteogenic metastases in bone. This study was undertaken to investigate the hypothesis that PAR2 activators released by PCa cells modulate osteo...

ba0005p213 | Chondrocytes and cartilage | ECTS2016

The vacuolar H+ ATPase V0 subunit D2 is associated with chondrocyte hypertrophy and supports chondrocyte differentiation

Ayodele Babatunde , Mirams Michiko , Pagel Charles , Mackie Eleanor

In a recent unbiased transcriptomic study of genes associated with equine osteochondrosis, we identified several novel cartilage genes. The current study was undertaken to determine whether these genes are regulated during chondrocyte hypertrophy, and to identify novel hypertrophy-associated genes for further study in vitro. Gene expression was investigated by quantitative PCR (qPCR) in different zones of growth cartilage microdissected from equine foetal metatarsal b...

ba0001pp247 | Chondrocytes and cartilage | ECTS2013

Expression of novel cartilage genes during maturation of cultured chondrocytes

Awodele Babatunde , Mirams Michiko , Pagel Charles , Mackie Eleanor

Formation and growth of long bones occur through the process of endochondral ossification, which depends on proliferation and hypertrophy of chondrocytes in growth cartilage. In a subtractive hybridization study of equine cartilage, we recently identified a number of genes, the roles of which in growth cartilage have not been characterized. A subset of these genes was found to be differentially expressed between the zones of equine growth cartilage. The genes encoding ATPase H...

ba0005ht3 | (1) | ECTS2016

Deletion of protease-activated receptor-2 improves bone and muscle pathology in dystrophin-deficient (mdx) mice

Esfandouni Neda Taghavi , Sanaei Reza , Samuel Chrishan , Pagel Charles , Mackie Eleanor

Duchenne muscular dystrophy (DMD) is associated with osteoporosis, and dystrophic (dystrophin-deficient) mdx mice show reduced bone mass characterised by decreased mineral apposition and elevated bone resorption. To investigate a potential role of the G-protein-coupled receptor protease-activated receptor-2 (PAR2) in the muscle and bone pathology associated with DMD, we established a colony of PAR2-null-mdx mice. Limb and diaphragm muscles, tibiae and ser...

ba0005oc2.6 | Bone mass and bone strength Wnt signalling | ECTS2016

N-cadherin maintains osteoprogenitor number and restrains Wnt signaling in osteoblasts

Fontana Francesca , Salazar Valerie , Brecks Cynthia , Revollo Leila , Mbalaviele Gabriel , Civitelli Roberto

We have shown that genetic ablation of Cdh2 (N−cadherin gene) in osteolineage cells results in osteopenia and decreased osteoprogenitor number. Paradoxically, others have shown that mice overexpressing Cdh2 in osteoblasts are also osteopenic; an action linked to a negative effect of N−cadherin (Ncad) on Wnt signaling, via sequestration of low density lipoprotein receptor−related protein−...

ba0001pp180 | Cell biology: osteoblasts and bone formation | ECTS2013

N-cadherin governs age-related osteoprogenitor cell determination in mice through modulation of Wnt5a and Wnt10b

Hay Eric , Dieudonne Francois-Xavier , Marty Caroline , Marie Pierre J

Senile osteoporosis and age-related osteopenia are associated with decreased osteoblastogenesis and increased bone marrow adipogenesis. The mechanisms controlling the fate determination of osteoblast to adipocyte differentiation of bone marrow stromal cells (BMSC) during aging are not known. We and others previously showed that the cell-cell adhesion molecule N-cadherin (N-Cadh) expressed in osteoblasts controls bone formation, but little is known about its role in BMSC fate d...

ba0003pp316 | Osteoporosis: treatment | ECTS2014

Odanacatib treatment improves lumbar vertebral bone mineral density and strength in orchiectomized rabbits

Duong Le T , Chen Charles , Pennypacker Brenda L

The selective cathepsin K inhibitor odanacatib (ODN) is currently in development for the treatment of postmenopausal osteoporosis. Our goal was to evaluate the effects of ODN vs alendronate (ALN) on bone mass and strength of lumbar vertebrae (LV) in orchiectomized (ORX) rabbits, a model of male osteoporosis. Adult male rabbits (11 months old) were subjected to sham- (n=20) or ORX-surgery (n=24/group) for 7.5 months before dosing initiated. ORX animals were ra...

ba0003pp163 | Cell biology: osteoclasts and bone resorption | ECTS2014

The molecular mechanism of n-butanol extracts of Panax notoginseng on RANKL-induced osteoclastogenesis in RAW264.7 cells

Hwang Hyo-In , Jang Young-Joo , Ko Seon-Yle

This study examined the anti-osteoclastogenic effect of n-butanol extracts of Panax notoginseng on the receptor activator of NF-kB ligand (RANKL) induced RAW264.7 cells. Panax notoginseng is commonly used to treat chronic liver disease. Notoginseng has many beneficial effects, such as the suppression of liver fibrosis and anti-cancer activities. Notoginseng contains several biologically active components, such as ginsenosides Rb1, Rg1...

ba0003pp114 | Cell biology: osteoblasts and bone formation | ECTS2014

N-linked glycosylation as a critical mechanism of PTH-resistance in osteoblasts in high glucose conditions

Picke Ann-Kristin , Hamann Christine , Rauner Martina , Hofbauer Lorenz C.

Type 2 diabetes mellitus impairs bone quality and increases fracture risk. We showed that diabetic ZDF rats have low bone mass due to impaired osteoblastogenesis, which can be partially reversed with an intermittent parathyroid hormone 1–84 (PTH) therapy. It remains unclear, why PTH treatment does not fully restore osteoblast (OB) function in diabetic conditions. Here, we tested if high glucose (HG) conditions lead to a partial PTH resistance in osteoblasts. Pre-osteoblas...